Literature DB >> 24918696

Total thyroidectomy with harmonic scalpel combined to gelatin-thrombin matrix hemostatic agent: is it safe and effective? A single-center prospective study.

Giovanni Docimo1, Salvatore Tolone1, Roberto Ruggiero2, Gianmattia del Genio1, Luigi Brusciano1, Angela Pezzolla3, Gianpaolo Jannelli1, Alfonso Bosco1, Domenico Parmeggiani1, Cosmo Cosenza1, Paolo Limongelli1, Ludovico Docimo1.   

Abstract

INTRODUCTION: Hemostasis during thyroidectomy is essential; however, the safest, most efficient and cost-effective way to achieve this is unclear. The aim of this study was to evaluate the outcome of total thyroidectomy (TT) performed with combination of harmonic scalpel (HS) and Floseal.
METHODS: Patients undergone TT were divided into two groups: HS + Floseal and traditional hemostasis groups. The primary endpoint was 24-h drain output and blood-loss requiring reintervention. Secondary endpoints included surgery duration, postsurgical complications and hypocalcemia rates.
RESULTS: Between September 2012 and January 2014, 165 patients were enrolled (100 to HS + Floseal, 65 to standard hemostasis); 80.5% female; mean age 42.3 years. The 24-h drain output was lower in the HS + Floseal group compared with standard TT. HS + Floseal also had a shorter mean surgery time (p < 0.0001) vs standard TT. No differences in post-surgical complications and in hypocalcemiarates between groups.
CONCLUSION: combination of Floseal plus the HS is effective and safe for TT and it provides a complementary hemostatic approach.
Copyright © 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Floseal; Gelatin-thrombin matrix topical hemostatic agent; Harmonic scalpel; Total thyroidectomy

Mesh:

Substances:

Year:  2014        PMID: 24918696     DOI: 10.1016/j.ijsu.2014.05.006

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  4 in total

1.  Risk factors for postoperative hypocalcemia.

Authors:  Giovanni Docimo; Roberto Ruggiero; Giuseppina Casalino; Gianmattia Del Genio; Ludovico Docimo; Salvatore Tolone
Journal:  Updates Surg       Date:  2017-04-25

Review 2.  Prevention and management of bleeding in thyroid surgery.

Authors:  Gabriele Materazzi; Carlo Enrico Ambrosini; Lorenzo Fregoli; Luigi De Napoli; Gianluca Frustaci; Valeria Matteucci; Piermarco Papini; Sohail Bakkar; Paolo Miccoli
Journal:  Gland Surg       Date:  2017-10

3.  Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: Review of over 4500 Thyroid and Parathyroid Procedures.

Authors:  Sarah C Oltmann; Amal Y Alhefdhi; Mohammad H Rajaei; David F Schneider; Rebecca S Sippel; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2016-05-02       Impact factor: 5.344

4.  Effectiveness of hemostatic agents in thyroid surgery for the prevention of postoperative bleeding.

Authors:  Martino Scaroni; Urs von Holzen; Christian A Nebiker
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.